Physician profile
Mina Shaker
NPI 1770977852
$5,111.10
in general payments reported to CMS, 2019-2025
48 companies · $585 in 2025
The $585 reported for 2025 was more than what 76% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $624 · 2020: $711 · 2021: $732 · 2022: $433 · 2023: $1,028 · 2024: $998 · 2025: $585.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,599 · Education: $11.56.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,599.33 |
| Education | $11.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,018.91 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbott Laboratories | $579.27 | 2021-2024 | Aveir, Gallant, Freestyle Libre |
| Amgen INC. | $365.85 | 2019-2024 | Repatha, Otezla |
| Abbvie INC. | $296.94 | 2021-2023 | Teflaro, Dalvance, Vraylar |
| Merck Sharp & Dohme LLC | $239.17 | 2020-2025 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $220.37 | 2019-2025 | Farxiga, Lokelma, Breztri |
| Glaxosmithkline, LLC. | $191.94 | 2019-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Novartis Pharmaceuticals Corporation | $158.59 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $157.02 | 2019-2021 | |
| Pfizer INC. | $156.39 | 2021-2025 | |
| Medtronic Vascular, INC. | $145.52 | 2019-2020 | |
| Genzyme Corporation | $127.88 | 2023 | |
| Dexcom, INC. | $119.84 | 2023-2025 | Dexcom G6 Transmitter |
| Sanofi-Aventis U.S. LLC | $105.51 | 2019-2025 | |
| Arthrosurface Incorporated | $99.86 | 2019 |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $92.73 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Gilead Sciences, INC. | $82.15 | 2023-2025 | |
| Medtronic Minimed, INC. | $73.02 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $71.93 | 2020-2024 | Xifaxan, Trulance |
| Lilly USA, LLC | $70.91 | 2019-2024 | Mounjaro |
| Exact Sciences Corporation | $65.92 | 2024-2025 | Cologuard Collection Kit |
| Amarin Pharma, INC. | $55.28 | 2019-2020 | |
| Medtronic, INC. | $52.94 | 2021-2023 | Minimed 780g |
| Viiv Healthcare Company | $52.83 | 2025 | Apretude |
| Currax Pharmaceuticals LLC | $49.76 | 2025 | Contrave |
| Madrigal Pharmaceuticals | $47.24 | 2024-2025 | Resmetirom, Rezdiffra |
| Biotronik Nro, INC. | $43.89 | 2023-2024 | Biotronik, Prospera |
| Allergan, INC. | $31.92 | 2019-2020 | |
| Xeris Pharmaceuticals, INC. | $30.71 | 2023-2024 | Gvoke Hypopen, Keveyis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.89 | 2021-2025 | |
| Neurocrine Biosciences, INC. | $27.24 | 2019-2020 | |
| Ironwood Pharmaceuticals, INC | $26.52 | 2020 | |
| Nestle Healthcare Nutrition INC. | $25.37 | 2021-2022 | |
| Boston Scientific Corporation | $17.88 | 2019 | |
| Arbor Pharmaceuticals, INC. | $16.93 | 2020 | |
| Intra-Sana Laboratories | $15.26 | 2024 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| Phathom Pharmaceuticals, INC. | $14.77 | 2024 | Voquezna |
| Paratek Pharmaceuticals, INC. | $14.67 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $14.28 | 2024 | Rexulti |
| Cleerly, INC. | $14.28 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Corcept Therapeutics | $14.06 | 2024 | Korlym |
| Cumberland Pharmaceuticals, INC. | $13.84 | 2022 | |
| Strongbridge US INC. | $13.81 | 2020 | |
| Horizon Therapeutics Plc | $12.26 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.23 | 2021 | |
| Radius Health, INC. | $10.95 | 2019 | |
| Echosens North America, INC. | $9.73 | 2025 | Fibroscan |
| Coala Life INC | $4.84 | 2023 | Coala Heart Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mina Shaker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.